IQI
ZVRA icon

Integrated Quantitative Investments’s Zevra Therapeutics ZVRA Stock Holding History

Integrated Quantitative Investments’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33,315
Closed -$310K – 542
2026
Q1 		$310K Sell
33,315
-22,813
-41% -$206K 0.06% 318
2025
Q4 		$503K Buy
+56,128
New +$531K 0.11% 256

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Integrated Quantitative Investments's ZVRA Position: Q2 2026 in Review

Integrated Quantitative Investments sold out of Zevra Therapeutics (ZVRA) in Q2 2026, closing a stake of 33,315 shares — an estimated $310K sold.

Integrated Quantitative Investments first reported a position in ZVRA in Q4 2025 and held it in 2 quarters. The position peaked at $503K in Q4 2025. 158 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Integrated Quantitative Investments reported no remaining Zevra Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Integrated Quantitative Investments sold 33,315 Zevra Therapeutics shares in Q2 2026, an estimated $310K.
  • Integrated Quantitative Investments first reported a position in Zevra Therapeutics in Q4 2025 and held it in 2 quarters.
  • Integrated Quantitative Investments's Zevra Therapeutics position peaked at $503K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.